Mucosal immunization with IpaD adjuvanted by IC31® elicits protection in a murine model of shigellosis
Authors:
- Gábor NagyGNGábor Nagy
- Markus HannerMHMarkus Hanner
- Benjamin WizelBWBenjamin Wizel
- Eszter NagyENEszter Nagy
Open Access
- 1 January 2011
- journal article
- Published by Elsevier in Procedia in Vaccinology
- Vol. 4, 36-41
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Bacterial Enteropathogens of Neonates Admitted to an Urban Diarrhoeal Hospital in BangladeshJournal of Tropical Pediatrics, 2008
- Vaccination against shigellosis: is it the path that is difficult or is it the difficult that is the path?Microbes and Infection, 2008
- Molecular Pathogenesis ofShigellaspp.: Controlling Host Cell Signaling, Invasion, and Death by Type III SecretionClinical Microbiology Reviews, 2008
- The versatility of Shigella effectorsNature Reviews Microbiology, 2008
- Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard roadNature Reviews Microbiology, 2007
- Antigenome technology: a novel approach for the selection of bacterial vaccine candidate antigensVaccine, 2005
- Optimization of Virulence Functions Through Glucosylation of Shigella LPSScience, 2005
- Small-fragment genomic libraries for the display of putative epitopes from clinically significant pathogensBioTechniques, 2003
- Isolation and Characterization of a Shigella flexneri Invasin Complex Subunit VaccineInfection and Immunity, 2000
- Molecular bases of epithelial cell invasion by Shigella flexneriAntonie van Leeuwenhoek, 1998